Geneseq Biosciences is a Melbourne based biotechnology company. We are pioneering the development of new “liquid biopsy” tests to help doctors individualise cancer diagnostics & treatment options. Our first test, MelaSeq, is designed to accurately detect the genetic (microRNA) fingerprint of active melanoma in blood. Follow our progress here or Twitter: https://twitter.com/geneseqbio